A detailed history of Franklin Resources Inc transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 16,290 shares of TRDA stock, worth $244,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,290
Previous 14,319 13.76%
Holding current value
$244,675
Previous $202,000 14.85%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$11.85 - $16.45 $23,356 - $32,422
1,971 Added 13.76%
16,290 $232,000
Q1 2024

May 13, 2024

BUY
$11.58 - $17.0 $12,888 - $18,921
1,113 Added 8.43%
14,319 $202,000
Q4 2023

Feb 09, 2024

BUY
$11.36 - $16.99 $150,020 - $224,369
13,206 New
13,206 $199,000

Others Institutions Holding TRDA

About Entrada Therapeutics, Inc.


  • Ticker TRDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,368,500
  • Market Cap $471M
  • Description
  • Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...
More about TRDA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.